drugset / Trial / NCT01239888

Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

NCT01239888

Phase 1 Unknown 15 enrolled The Alfred Monash University · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether an oxytocin ad-on, or oxytocin and tibolone ad-on can induce a response to antidepressants in patients with treatment resistant depression.

Timeline

Start
2012-01
Primary completion
2012-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 20 iu Intranasal
Comparator Tibolone Other / unclassified 2.5 mg Oral